Trey Mancini believes it’s his responsibility — maybe it’s his calling — to make his health journey public. From his Stage 3 colon cancer diagnosis in March 2020 through his surgery, his six months of ...

In this study, researchers aimed to assess guideline-concordant colorectal cancer care to quantify how much variation is ...

Trends in surveillance testing after treatment for colorectal cancer remained relatively stable recently, and patients who overutilized surveillance measures had quicker recurrence detection but ...

Retrospective health care claims database analysis of direct medical costs of newly diagnosed patients (pts) with hepatocellular carcinoma (HCC) in the United States. Background: Relapse after ...

A pair of common tests might help colorectal cancer patients who have undergone surgery remain cancer-free, British researchers say. Both a standard CT scan and a blood test known as CEA ...

Blood test for minimal residual disease (MRD) now covered to monitor for disease recurrence after curative intent treatment Tissue-free approach addresses need for cancer patients who have no tissue ...

Successful HZO Ferroelectric Wafer Loops Confirm Functionality Across FAMES Sites, And Advance Europe’s Collaborative Platform for Next-Generation Non-Volatile Memory GRENOBLE, France and DRESDEN, ...

A new secondary analysis of a randomized clinical trial examined 10-year mortality data from 2456 patients diagnosed with stage II or III colorectal cancer. Improved treatments for metastatic disease ...

A cohort of 250 patients diagnosed with stage II or III CRC in 2004 and alive 42 months after diagnosis was identified from health administrative data in Manitoba, Canada. Colonoscopy, liver imaging, ...

CEA-Leti and Fraunhofer IPMS have successfully completed the first exchange of ferroelectric memory wafers within the FAMES Pilot Line, marking a pivotal milestone in establishing a shared European ...